In a continued effort to enhance healthcare awareness and support for rare diseases, Chonburi Hospital, in collaboration with Novo Nordisk Pharma (Thailand) Ltd. ('Novo Nordisk'), hosted the 'Unlock ...

By Maggie Fick and Jacob Gronholt-Pedersen LONDON/COPENHAGEN (Reuters) -A boardroom shake-up at Novo Nordisk has handed ...

Another week, another twist in the turnaround efforts at Novo Nordisk, the maker of the blockbuster Ozempic and Wegovy weight ...

Novo Nordisk (NVO) recruits top healthcare analyst Michael Novod, a long time bull of the company, as head of its investor ...

Novo Nordisk A/S found a new leader for its investor relations department in an equity analyst who has recommended buying ...

Monlunabant shows significant and clinically meaningful weight loss over 16 weeks in patients with obesity and metabolic ...

Novo Nordisk's top investor moved to take control of the drugmaker's board on Tuesday, vowing a sharper focus on the key U.S.

Denmark's Novo Nordisk said Tuesday it would replace more than half of its board, including the chair, as the Ozempic and ...

The Ozempic maker’s controlling shareholder intends to replace seven directors, including the Denmark-based company’s ...

Novo Nordisk will replace chair Helge Lund and six independent directors next month in a major boardroom shakeup following a ...

The changing of the guard at Novo Nordisk took another turn this week as the company revealed that seven members of its board ...